Article

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

2021-03-29

Abstract excerpt

Besides external high-energy photon or proton beam therapy, targeted radionuclide therapy (TRNT) is an alternative approach to deliver radiation to cancer cells. TRNT is distributed within the body by the vascular system and allows targeted irradiation of a primary tumor and all its metastases, resulting in substantially less collateral damage to normal tissues as compared to ex-ternal beam radiotherapy (EBRT). It...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 62c5076c-65f5-5d0c-91bf-7075b20a3e8e
DOI: 10.20944/preprints202103.0699.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to BedsideDOI 10.20944/preprints202103.0699.v1Read

Biomedical Applications of Targeted Drug Delivery, Nanotheranostic and Nuclear MedicineSemantic proximity Read

<p class="MsoNormal" style="margin-bottom: 12.0pt; text-align: left; mso-line-height-alt: 14.0pt; layout-grid-mode: char; mso-layout-grid-align: none;" align="left"><sup>161</sup>Tb-BPAMD as a High-Affinity Agent for Skeletal Targeting: Radiochemical and Biodistribution InsightsSemantic proximity Read

Theranostics of Bone Metastases: The Role and Prospects of Bisphosphonate RadiopharmaceuticalsSemantic proximity Read

Multi-Curie Production of Gallium-68 on a Biomedical Cyclotron and Automated Radiolabelling of PSMA-11 and DOTATATESemantic proximity Read

Multi-curie Production of Gallium-68 on a Biomedical Cyclotron and Automated Radiolabelling of PSMA-11 and DOTATATESemantic proximity Read

Low Dose Radiation by Radiopharmaceutical Therapy Enhances GD2 <i>TRAC-</i> CAR T Cells Efficacy in Localized NeuroblastomaSemantic proximity Read

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy. Implications for Radiopharmaceutical Repurposing (Beyond Oncology)Semantic proximity Read

Nuclear medicine and molecular imaging advances in the 21st centurySemantic proximity Read

A general approach to reduce off-target radioactivity in vivo via Tetrazine-Knock-Out (TKO)Semantic proximity Read

Preclinical evaluation of [13xLa]La-FAP-2286 as a novel theranostic agent for tumors expressing fibroblast activation proteinSemantic proximity Read

Mathematical Modeling Unveils Optimization Strategies for Targeted Radionuclide Therapy of Blood CancersSemantic proximity Read

Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor modelsSemantic proximity Read